Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
DGX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$125.42 - $178.87
Previous CloseN/A
Volume143.08K
Average Volume (3M)1.20M
Market Cap
$18.78B
Enterprise Value$23.70B
Total Cash (Recent Filing)$463.20M
Total Debt (Recent Filing)$3.12B
Price to Earnings (P/E)22.1
Beta0.21
Next Earnings
Apr 22, 2025EPS Estimate
2.16Next Dividend Ex-Date
Apr 07, 2025Dividend Yield1.77%
Share Statistics
EPS (TTM)7.70
Shares Outstanding110,978,065
10 Day Avg. Volume1,111,883
30 Day Avg. Volume1,197,701
Financial Highlights & Ratios
PEG Ratio8.62
Price to Book (P/B)N/A
Price to Sales (P/S)1.88
Price to Cash Flow (P/CF)10.00
P/FCF Ratio9.10
Enterprise Value/Market Cap1.26
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit7.31
Enterprise Value/Ebitda12.51
Forecast
1Y Price Target
$182.36Price Target Upside8.57% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
---
Bulls Say, Bears Say
Bulls Say
Financial StabilityDGX is considered an attractive investment opportunity in an uncertain macroeconomic environment given high earnings visibility, strong cash flow generation, and a solid balance sheet.
Growth StrategyQuest Diagnostics aims for faster than market growth by expanding access with new health plan relationships and partnerships with larger enterprise accounts.
Market PositionQuest Diagnostics' key growth pillars are supported by favorable macro trends in the US lab market, enhancing its competitive position.
Bears Say
Regulatory ChallengesPotential challenges to achieving earnings growth include the possibility of PAMA cuts in 2026, which could impact earnings growth targets for that year.
Short-term Earnings PressureThe reaffirmed 2025 guidance includes a $0.10 EPS weather headwind along with investments in Project Nova and regulatory compliance, impacting short-term earnings.
Weather ImpactWeather headwinds are expected to impact Quest Diagnostics' revenue and earnings per share.
---
Ownership Overview
0.47% Insiders
30.86% Mutual Funds
15.71% Other Institutional Investors
24.37% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $125.42 and its highest was $178.87 in the past 12 months.
What is Quest Diagnostics’s market cap?
Quest Diagnostics’s market cap is $18.78B.
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Apr 22, 2025 which is in 19 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Jan 30, 2025. The company reported $2.23 earnings per share for the quarter, beating the consensus estimate of $2.186 by $0.044.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.8 which represents an annual dividend yield of 1.77%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is 2.16.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 110,978,065 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.23 in its last earnings report, beating expectations of $2.186. Following the earnings report the stock price went up 5.616%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Currently, no hedge funds are holding shares in DGX
---
Quest Diagnostics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$182.36 (8.57% Upside)
$182.36 (8.57% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 75%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 67.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $417.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.2%
Last 30 Days ▲ 2.3%
Last 30 Days ▲ 2.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
28.25%
12-Months-Change
Fundamentals
Return on Equity
13.24%
Trailing 12-Months
Asset Growth
15.20%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
---
DGX Company Deck
---
DGX Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Quest Diagnostics reported strong revenue growth driven by acquisitions and expansions in Advanced Diagnostics. Despite challenges like weather impacts and pricing pressure in the hospital segment, the overall sentiment remains positive due to strategic acquisitions, improvements in consumer testing, and operational efficiencies.Read More>---
DGX Revenue Breakdown
97.39% Diagnostic Information Services
2.61% All other operating segments
---
DGX Stock 12 Month Forecast
Average Price Target
$182.36
▲(8.57% Upside)
Technical Analysis
Best Analysts Covering DGX
1 Year
1 Year Success Rate
12/16 ratings generated profit
1 Year Average Return
+9.89%
reiterated a buy rating 15 days ago
Copying Eric Coldwell's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +9.89% per trade.
---